Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
65 Cards in this Set
- Front
- Back
Pharm 22 Sedative Hypnotic Drugs
|
Seditive Hypnotic Drugs
|
|
seditive effect
|
reduce anxiety exert calming effect
|
|
hypnotic drug
|
produce drowsiness and encourage sleep
|
|
target for BZ drugs
|
GABA a receptor
|
|
subunits of GABA a receptor
|
alpha, beta , gamma
|
|
benzodiazepine receptor location
|
gamma 2 subunit at interface with alpha (1 or 2)
|
|
BZ1 vs BZ2
|
if it includes alpha 1 it is a BZ1 if it includes alpha 2 it is a BZ2
|
|
BZ increase the ____________ of Cl- channel oppening by GABA
|
frequency "ben wants to do it more"
|
|
low dose BZ activity
|
reduction of anxiety, sedation
|
|
high dose BZ activit
|
hypnotic / muscle relaxant
|
|
other effects of BZ
|
anterograe amnesia, anticonvulsant
|
|
effective for short term and long term panic disorders
|
alprazolam
|
|
useful for tx of skeletal muscle spasms in conitions such as MS and cerebral palsy
|
diazepam
|
|
DOA alprazolam
|
intermediate (10-20h)
|
|
DOA estazolam
|
intermediate (10-20h)
|
|
DOA clorazepate
|
long (1-3 days)
|
|
DOA oxazepam
|
short (3-8h)
|
|
DOA lorazepam
|
intermediate (10-20h)
|
|
DOA temazepam
|
intermediate (10-20h)
|
|
DOA chlordiazepoxide
|
long (1-3 days)
|
|
DOA flurazepam
|
long (1-3 days)
|
|
DOA triazolam
|
short (3-8h)
|
|
DOA quazepam
|
long (1-3 days)
|
|
drug used for induction of anesthesia
|
midazolam
|
|
diazepam and lorazepam used for what siezure d/o
|
grand mal termination and status epilepticus
|
|
BZ used for acute alcohol withdrawl
|
chlordiazepoxite , clorazepate, diazepam, oxazepam
|
|
commonly perscribed BZ for sleep disorders
|
flurazepam (long) temazepam (intermediate) triazolam (short)
|
|
BZ for people who cant fall asleep
|
triazolam
|
|
BZ for people who cant stay asleep
|
temazepam
|
|
withdrawl effects occur more rapidly with what BZ
|
short acting
|
|
most common SE for BZ
|
drowsiness and confusion
|
|
DOC for BZ overdose
|
flumazenil
|
|
MOA flumazenil
|
GABA antagonist
|
|
SE of flumazenil
|
BZ withdrawl signs
|
|
MOA of buspirone
|
5-HT 2a receptor agonist
|
|
indication buspirone
|
chronic GAD management
|
|
adverse effects of Buspirone
|
nausea dizziness moreso than drowsiness fatigue and concentration issues (opposite trend for BZ drugs)
|
|
disadvantages of barbituates
|
tolerane, CYP induction, dependance, severe withdrawl, coma in toxic doses
|
|
MOA barbituates
|
interaction with GABA a receptor (distinct binding from BZ) ; keeps CL- channel open longer when GABA binds (BARB likes to do it longer)
|
|
ultra short acting barbituate
|
thiopental
|
|
short acting barbituates (3)
|
pento , seco, amobarbital
|
|
long acting (1-2 days) barbituates
|
phenobarbitol
|
|
dose dependent effets of barbituates
|
low to high (sedation, hypnosis, anesthesia, coma, death)
|
|
enzyme activity barbituates
|
CYP inducers
|
|
barbituate used to induce anesthesia
|
thiopental
|
|
barbituate used in long term manangment of siezures
|
phenobarbitol
|
|
barbituates are synergistic with this CNS depressant
|
ethanol
|
|
doing this to urine will enhance phenobarbitol elimination
|
alkalinization
|
|
zolpiden acts on this receptor
|
BZ1
|
|
metabolism of zolpidem
|
CYP450 (3A4)
|
|
zaleplon
|
similar to zolpidem but fewer residual effects, rapid elimination, CYP3A4 metabolism
|
|
eszopiclone
|
oral non BZ that acts on BZ1 and is used for tx of insomnia
|
|
onset/duration for non BZ hypnotics (zolpidem, zaleplon, eszopiclone, ramelteon)
|
all have rapid onset (20-30min) zaleplon is a 3 hour duration, zolpidem is 5, the other 2 are 7 hours
|
|
MOA of ramelteon
|
selective agonist of MT1 and MT2 melatonin receptors
|
|
indication of ramelton
|
long term management of insomnia with increased sleep latency as primary complaitn
|
|
disadvantages of use of BZ class (2)
|
impaired intellectual/motor function, potential for dependence/withdrawl
|
|
advantages of clonazepam an clorazepate
|
chronic siezure therapy
|
|
advantages of flurazepam and quazepam
|
less potent and more slowly eliminated, no rebound insomnia on withdrawl
|
|
DOC for panic disorders
|
alprazolam
|
|
BZ with no Phase 1 metabolism and considered safe for pt with hepatic impairment
|
lorazepam, temazepam
|
|
withdrawl of this drug results in rebound insomnia
|
triazolam
|
|
low addiction potential, useful for long term anziety, doesn’t increase CNS depression of EtOH
|
buspirone
|
|
diadvantage to buspirone
|
no muscle relaxation, no anticonvulsant, long time till onset of action
|
|
advantae to eszopiclone
|
useful tx for insomina for up to 6 months
|
|
advantages to zaleplon and zolpidem
|
minimal rebound insomnia, minimal withdrawl, little tolerance
|